We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
Early TIPS for Ascites Study
Updated: 12/19/2012
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Early TIPS for Ascites Study
Updated: 12/19/2012
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Click here to add this to my saved trials
Early TIPS for Ascites Study
Updated: 12/19/2012
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Early TIPS for Ascites Study
Updated: 12/19/2012
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Click here to add this to my saved trials
Early TIPS for Ascites Study
Updated: 12/19/2012
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Early TIPS for Ascites Study
Updated: 12/19/2012
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Click here to add this to my saved trials
Early TIPS for Ascites Study
Updated: 12/19/2012
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Early TIPS for Ascites Study
Updated: 12/19/2012
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Click here to add this to my saved trials
Sedation With Dexmedetomidine During Cardiac Catheterization
Updated: 1/9/2013
The Pharmacodynamics, Safety, and Pharmacokinetics of Sedation With Dexmedetomidine in Children Undergoing Hemodynamic Cardiac Catheterization With Special Reference to the Pulmonary Vascular Bed
Status: Enrolling
Updated: 1/9/2013
Sedation With Dexmedetomidine During Cardiac Catheterization
Updated: 1/9/2013
The Pharmacodynamics, Safety, and Pharmacokinetics of Sedation With Dexmedetomidine in Children Undergoing Hemodynamic Cardiac Catheterization With Special Reference to the Pulmonary Vascular Bed
Status: Enrolling
Updated: 1/9/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Updated: 1/11/2013
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
Status: Enrolling
Updated: 1/11/2013
Click here to add this to my saved trials
Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard Therapy
Updated: 1/15/2013
Impedance Cardiographic Assessment of Gravidas With Severe Hypertension (ICASH)to Assess Impact of Standard Therapy on Hemodynamic Parameters - A Pilot Study
Status: Enrolling
Updated: 1/15/2013
Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard Therapy
Updated: 1/15/2013
Impedance Cardiographic Assessment of Gravidas With Severe Hypertension (ICASH)to Assess Impact of Standard Therapy on Hemodynamic Parameters - A Pilot Study
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
Smoking Study With Behavioral Therapy for Hypertensive Patients
Updated: 1/16/2013
Contingency Management for Initiating Smoking Abstinence in Patients With Hypertension
Status: Enrolling
Updated: 1/16/2013
Smoking Study With Behavioral Therapy for Hypertensive Patients
Updated: 1/16/2013
Contingency Management for Initiating Smoking Abstinence in Patients With Hypertension
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
Updated: 1/16/2013
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
Status: Enrolling
Updated: 1/16/2013
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
Updated: 1/16/2013
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
Status: Enrolling
Updated: 1/16/2013
Click here to add this to my saved trials
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Click here to add this to my saved trials
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Click here to add this to my saved trials
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Click here to add this to my saved trials
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Click here to add this to my saved trials
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Azilsartan Medoxomil Study in Hypertensive Children
Updated: 1/28/2013
A Comparative Single-Dose Pharmacokinetic and Safety Study of TAK-491 Between Infants, Children, and Adolescents With Hypertension and Healthy Adults
Status: Enrolling
Updated: 1/28/2013
Click here to add this to my saved trials
Prevalence, Awareness and Management of Hypertension in Acute Care Personnel
Updated: 2/5/2013
Prevalence, Awareness and Management of Hypertension in Acute Care Personnel
Status: Enrolling
Updated: 2/5/2013
Prevalence, Awareness and Management of Hypertension in Acute Care Personnel
Updated: 2/5/2013
Prevalence, Awareness and Management of Hypertension in Acute Care Personnel
Status: Enrolling
Updated: 2/5/2013
Click here to add this to my saved trials
Measuring Adherence to Control Hypertension
Updated: 2/11/2013
Electronically Measuring Medication Adherence to Improve the Management of Uncontrolled Hypertension
Status: Enrolling
Updated: 2/11/2013
Measuring Adherence to Control Hypertension
Updated: 2/11/2013
Electronically Measuring Medication Adherence to Improve the Management of Uncontrolled Hypertension
Status: Enrolling
Updated: 2/11/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Updated: 2/13/2013
Milrinone Pharmacokinetics and Pharmacodynamics in Newborns With Persistent Pulmonary Hypertension of the Newborn - a Pilot Study to Enable a Randomized Trial of Intervention
Status: Enrolling
Updated: 2/13/2013
Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Updated: 2/13/2013
Milrinone Pharmacokinetics and Pharmacodynamics in Newborns With Persistent Pulmonary Hypertension of the Newborn - a Pilot Study to Enable a Randomized Trial of Intervention
Status: Enrolling
Updated: 2/13/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Updated: 2/13/2013
Milrinone Pharmacokinetics and Pharmacodynamics in Newborns With Persistent Pulmonary Hypertension of the Newborn - a Pilot Study to Enable a Randomized Trial of Intervention
Status: Enrolling
Updated: 2/13/2013
Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Updated: 2/13/2013
Milrinone Pharmacokinetics and Pharmacodynamics in Newborns With Persistent Pulmonary Hypertension of the Newborn - a Pilot Study to Enable a Randomized Trial of Intervention
Status: Enrolling
Updated: 2/13/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Updated: 2/13/2013
Milrinone Pharmacokinetics and Pharmacodynamics in Newborns With Persistent Pulmonary Hypertension of the Newborn - a Pilot Study to Enable a Randomized Trial of Intervention
Status: Enrolling
Updated: 2/13/2013
Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Updated: 2/13/2013
Milrinone Pharmacokinetics and Pharmacodynamics in Newborns With Persistent Pulmonary Hypertension of the Newborn - a Pilot Study to Enable a Randomized Trial of Intervention
Status: Enrolling
Updated: 2/13/2013
Click here to add this to my saved trials
The Impact of Nebivolol Versus Metoprolol on Quality of Life
Updated: 2/14/2013
The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Status: Enrolling
Updated: 2/14/2013
The Impact of Nebivolol Versus Metoprolol on Quality of Life
Updated: 2/14/2013
The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Status: Enrolling
Updated: 2/14/2013
Click here to add this to my saved trials
The Impact of Nebivolol Versus Metoprolol on Quality of Life
Updated: 2/14/2013
The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Status: Enrolling
Updated: 2/14/2013
The Impact of Nebivolol Versus Metoprolol on Quality of Life
Updated: 2/14/2013
The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Status: Enrolling
Updated: 2/14/2013
Click here to add this to my saved trials
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Updated: 2/25/2013
Evaluation of Exercise Intolerance and Right Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Status: Enrolling
Updated: 2/25/2013
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Updated: 2/25/2013
Evaluation of Exercise Intolerance and Right Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Status: Enrolling
Updated: 2/25/2013
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
Updated: 3/4/2013
An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients
Status: Enrolling
Updated: 3/4/2013
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
Updated: 3/4/2013
An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients
Status: Enrolling
Updated: 3/4/2013
Click here to add this to my saved trials
Community-based Approaches to Treating Hypertension and Colon Cancer Prevention
Updated: 3/12/2013
Community-based Approaches to Treating Hypertension and Colon Cancer Prevention
Status: Enrolling
Updated: 3/12/2013
Community-based Approaches to Treating Hypertension and Colon Cancer Prevention
Updated: 3/12/2013
Community-based Approaches to Treating Hypertension and Colon Cancer Prevention
Status: Enrolling
Updated: 3/12/2013
Click here to add this to my saved trials
The DASH Diet for Adults With Uncontrolled Asthma
Updated: 3/18/2013
A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma
Status: Enrolling
Updated: 3/18/2013
The DASH Diet for Adults With Uncontrolled Asthma
Updated: 3/18/2013
A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma
Status: Enrolling
Updated: 3/18/2013
Click here to add this to my saved trials
The DASH Diet for Adults With Uncontrolled Asthma
Updated: 3/18/2013
A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma
Status: Enrolling
Updated: 3/18/2013
The DASH Diet for Adults With Uncontrolled Asthma
Updated: 3/18/2013
A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma
Status: Enrolling
Updated: 3/18/2013
Click here to add this to my saved trials
3-D Transcranial Ultrasound Analysis Study
Updated: 3/28/2013
3-D Transcranial Ultrasound Analysis Using Definity Injectable Suspension
Status: Enrolling
Updated: 3/28/2013
3-D Transcranial Ultrasound Analysis Study
Updated: 3/28/2013
3-D Transcranial Ultrasound Analysis Using Definity Injectable Suspension
Status: Enrolling
Updated: 3/28/2013
Click here to add this to my saved trials
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
Updated: 4/2/2013
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
Status: Enrolling
Updated: 4/2/2013
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
Updated: 4/2/2013
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
Status: Enrolling
Updated: 4/2/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Updated: 4/8/2013
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials